![Joanne Quan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joanne Quan
Plus aucun poste en cours
Fortune : 2 M $ au 31/08/2026
Profil
Joanne M.
Quan was the founder of Nuvig Therapeutics, Inc., founded in 2022, serving as Chief Medical Officer from 2022 to 2023.
Former jobs include Chief Medical Officer at Modis Therapeutics, Inc. from 2018 to 2021; Chief Medical Officer at Eiger BioPharmaceuticals, Inc.; Chief Medical Officer at Mirum Pharmaceuticals, Inc. from 2024 to 2026; Vice President-Clinical & Regulatory Affairs at Bayhill Therapeutics, Inc. from 2008 to 2011; Vice President-Clinical Development at Arena Pharmaceuticals, Inc. from 2012 to 2014; Vice President-w Product Clinical Development at InterMune, Inc. from 2014 to 2015; Senior Director-Clinical Development at ALZA Corp.
in 2008; Medical Director at Genentech, Inc. from 2000 to 2005; and Director-Clinical Research at PathoGenesis Corp from 1996 to 2000.
Education includes undergraduate studies at the University of California, Berkeley and a doctorate from Stanford University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/03/2026 | 18 864 ( 0,03% ) | 2 M $ | 31/08/2026 |
Anciens postes connus de Joanne Quan
| Sociétés | Poste | Fin |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 02/09/2026 |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Fondateur | 04/10/2023 |
Modis Therapeutics, Inc.
 Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology for developing disease modifying therapies | Directeur Technique/Scientifique/R&D | 01/08/2021 |
| INTERMUNE INC | Corporate Officer/Principal | 01/01/2015 |
| ARENA PHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/01/2014 |
Formation de Joanne Quan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Modis Therapeutics, Inc.
Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology for developing disease modifying therapies | Commercial Services |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
